The screwup by Greg Meyers continues after a half baked BI&A takeover, but hey, you should not expect any less with his history.
William Mayo with no Research IT experience out after 2 years of tomfuckery and kicking out high achievers who knew something about Research. Bought in as an SVP replacing the previous VP level Celgene guy for no reason and now has another VP reporting to him. Talk about the level of waste.
Lisa Delin - DEI only credentials with zero Commercial experience and no significant value delivered in BMS, let us see how far this ridiculous puppet clown show will go
Sydney Klein’s bloated infrastructure and cyber function - Half of this group as in all pharma should be outsourced or moved to India, instead they have 4 VPs, an army of EDs & senior directors and very large teams in the US. Any other pharma CIO will laugh at this waste, but yeah it is a good thing that BMS LT has no clue this function really is a commodity. A wannabe CIO (LOL, or maybe it will happen with an incompetent BMS LT) and the self appointed DEI queen with no real business IQ Sydney is way over her head. This group has no accountability for any business growth or pipeline progress. How is this cost center function continuing to grow?